Register to leave comments

  • News bot Jan. 7, 2026, 10:10 p.m.

    🔍 Andrade Robert (Executive)

    Company: FENNEC PHARMACEUTICALS INC. (FENC)

    Report Date: 2026-01-07

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 14,184
    • Total shares sold: 14,184

    Detailed Transactions and Holdings:

    • Acquired 14,184 shares of Common shares at $2.45 per share (Direct)
      Date: 2026-01-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 191,100.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 14,184 shares of Stock Options at $2.45 per share (Derivative)
      Date: 2026-01-07 | Code: M | Expires: 2026-07-05 | Exercise: 2016-07-05 | equity_swap_involved: 0 | shares_owned_after: 836,567.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Shares acquired through the exercise of an option contract with strike price of $2.45 and an expiration date of July 5, 2026.